SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-21-004161
Filing Date
2021-09-08
Accepted
2021-09-08 16:24:44
Documents
14
Period of Report
2021-09-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K avid_i8k.htm   iXBRL 8-K 30829
2 PRESS RELEASE ISSUED SEPTEMBER 8, 2021 avid_8k-9901.htm EX-99.1 77126
3 GRAPHIC image_001.jpg GRAPHIC 4096
  Complete submission text file 0001683168-21-004161.txt   299822

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cdmo-20210908.xsd EX-101.SCH 3021
5 XBRL LABEL FILE cdmo-20210908_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE cdmo-20210908_pre.xml EX-101.PRE 22356
7 EXTRACTED XBRL INSTANCE DOCUMENT avid_i8k_htm.xml XML 3603
Mailing Address 2642 MICHELLE DRIVE, SUITE 200 TUSTIN CA 92780
Business Address 2642 MICHELLE DRIVE, SUITE 200 TUSTIN CA 92780 714.508.6100
Avid Bioservices, Inc. (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-32839 | Film No.: 211242387
SIC: 2834 Pharmaceutical Preparations